Your browser doesn't support javascript.
loading
Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours.
McDaid, William J; Greene, Michelle K; Johnston, Michael C; Pollheimer, Ellen; Smyth, Peter; McLaughlin, Kirsty; Van Schaeybroeck, Sandra; Straubinger, Robert M; Longley, Daniel B; Scott, Christopher J.
Afiliação
  • McDaid WJ; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
  • Greene MK; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
  • Johnston MC; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
  • Pollheimer E; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
  • Smyth P; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
  • McLaughlin K; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
  • Van Schaeybroeck S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
  • Straubinger RM; Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, NY 14260-1200, USA.
  • Longley DB; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
  • Scott CJ; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK. c.scott@qub.ac.uk.
Nanoscale ; 11(42): 20261-20273, 2019 Nov 14.
Article em En | MEDLINE | ID: mdl-31626255
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Resistencia a Medicamentos Antineoplásicos / Nanopartículas / Cetuximab / Ado-Trastuzumab Emtansina / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nanoscale Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoconjugados / Resistencia a Medicamentos Antineoplásicos / Nanopartículas / Cetuximab / Ado-Trastuzumab Emtansina / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nanoscale Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido